Anti-Cdc6 [cdc6 9H8/5]

Cdc6 is essential for assembling the pre-replicative complex that forms at origins of DNA replication in the G1 phase of the cell cycle in budding yeast (S. cerevisiae).

Contributors

Institute
Cancer Research UK, London Research Institute: Clare Hall Laboratories
SKU: 151190
Product description: Cdc6 is essential for assembling the pre-replicative complex that forms at origins of DNA replication in the G1 phase of the cell cycle in budding yeast (S. cerevisiae).
Alternate name: Cell Division Cycle 6; Cdc18-Related Protein; CDC6-Related Protein; P62(Cdc6); HsCDC18; CDC18L; HsCDC6; CDC6 Cell Division Cycle 6 Homolog
Conjugation: Unconjugated
Isotype: IgG1
Immunogen: cdc6 from S.Cerevisiae.
Cat. #: 151190
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Cell biology;Genetics
Application: IHC ; IP ; WB
Target: Cell-division cycle protein 6 (cdc6)
Reactivity: Saccharomyces cerevisiae
Clone: cdc6 9H8/5
Host: Mouse
Class: Monoclonal
Target background: Cdc6 is essential for assembling the pre-replicative complex that forms at origins of DNA replication in the G1 phase of the cell cycle in budding yeast (S. cerevisiae).
Format: Liquid
Concentration: 1 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -15° C to -25° C
Shipping conditions: Dry ice
References:

Evrin et al. 2013. Nucleic Acids Res. 41(5):3162-72. PMID: 23376927.

A yeast GSK-3 kinase Mck1 promotes Cdc6 degradation to inhibit DNA re-replication.

Ikui et al. 2012. PLoS Genet. 8(12):e1003099. PMID: 23236290.

Zhang et al. 2007. Cancer Res. 67(8):3827-34. PMID: 17440097.

Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.

Perkins et al. 2001. EMBO J. 20(17):4836-45. PMID: 11532947.

Separate SCF(CDC4) recognition elements target Cdc6 for proteolysis in S phase and mitosis.

Donovan et al. 1997. Proc Natl Acad Sci U S A. 94(11):5611-6. PMID: 9159120.

Cdc6p-dependent loading of Mcm proteins onto pre-replicative chromatin in budding yeast.

Images

View Gallery
Adapted from Ikui et al. 2012. PLoS Genet. 8(12)

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.